First human test of experimental ALS injection begins
NCT ID NCT02039401
Summary
This early-stage study aimed to check if an experimental injection called VM202 is safe for people with ALS (Lou Gehrig's disease). It involved 18 adults recently diagnosed with ALS to see what side effects might occur. The main goal was to understand safety, not to prove if the treatment works to slow the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.